Cancer Family
Malignant Breast Neoplasm
CI-CAN-00000227Explore in graph →
Top-level2,626 active trials43 approved drugs310 evidence items
- NCIt
- C9335
- OncoTree
- BREAST
- ICD-10
- C50
- DOID
- 1612
- Other
- 2 more codes
Loading cancer entity…
Cancer Family
CI-CAN-00000227Explore in graph →
Clinical trials
12,360 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (1,368)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00060320 | Black Cohosh in Treating Hot Flashes in Women Who Have or Who Are At Risk of Developing Breast Cancer | completed | Phase 3 | 132 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT02112149 | Effect of the LIVESTRONG at the YMCA Exercise Program on Cancer Related Outcomes in Cancer Survivors | completed | Phase 3 | 200 | Yale UniversityOTHER | 1 | Jul 13, 2016 | clinicaltrials |
| NCT00041171 | Docetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By Surgery | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT00053339 | Trastuzumab With or Without Tamoxifen in Treating Women With Progressive Stage IV Breast Cancer | withdrawn | Phase 3 | 0 | Alliance for Clinical Trials in OncologyOTHER | 0 | Jul 12, 2016 | clinicaltrials |
| NCT00046891 | EGb761 in Maintaining Mental Clarity in Women Receiving Chemotherapy for Newly Diagnosed Breast Cancer | completed | Phase 3 | 226 | Alliance for Clinical Trials in OncologyOTHER | 1 | Jul 6, 2016 | clinicaltrials |
| NCT02802826 | Studying Tailored Exercise Prescriptions in Breast Cancer Patients(STEPS) | unknown | Phase 3 | 100 | Loughborough UniversityOTHER | 1 | Jun 16, 2016 | clinicaltrials |
| NCT02383030 | Fulvestrant as Maintenance Therapy After First-line Chemotherapy in HER2 - Postmenopausal MBC Patients(FUMANCE) | unknown | Phase 3 | 156 | Consorzio OncotechOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT02394496 | Overcoming Endocrine Resistance in Metastatic Breast Cancer(OVER) | unknown | Phase 3 | 396 | Consorzio OncotechOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT02404051 | Fulvestrant and EVerolimus Plus EXemestane in Metastatic Breast Cancer(FEVEX) | unknown | Phase 3 | 745 | Consorzio OncotechOTHER | 1 | Jun 15, 2016 | clinicaltrials |
| NCT02794324 | The HeartSpare Study (Stage I) | completed | Phase 2 / Phase 3 | 57 | Royal Marsden NHS Foundation TrustOTHER | 1 | Jun 9, 2016 | clinicaltrials |
| NCT00486668 | A Study of AC Followed by a Combination of Paclitaxel Plus Trastuzumab or Lapatinib or Both Given Before Surgery to Patients With Operable HER2 Positive Invasive Breast Cancer | unknown | Phase 3 | 529 | NSABP Foundation IncNETWORK | 3 | Jun 6, 2016 | clinicaltrials |
| NCT02690636 | Conventional Versus Hypofractionated Radiotherapy in Node Positive Breast Cancer | unknown | Phase 3 | 500 | Ain Shams UniversityOTHER | 1 | Jun 1, 2016 | clinicaltrials |
| NCT02097459 | Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer | unknown | Phase 3 | 600 | Peking Union Medical College HospitalOTHER | 1 | May 25, 2016 | clinicaltrials |
| NCT01001728 | SuPr Study (Supine Versus Prone Treatment Position in Breast Radiotherapy)(SuPr) | completed | Phase 3 | 25 | Royal Marsden NHS Foundation TrustOTHER | 1 | May 23, 2016 | clinicaltrials |
| NCT00194571 | Enhancing Connections: Helping the Mother With Breast Cancer Support Her Child(EC R01) | completed | Phase 3 | 181 | University of WashingtonOTHER | 1 | May 20, 2016 | clinicaltrials |
| NCT00402519 | APBI Versus EBRT Therapy After Breast Conserving Surgery for Low-risk Breast Cancer | unknown | Phase 3 | 1,300 | University of Erlangen-Nürnberg Medical SchoolOTHER | 5 | May 13, 2016 | clinicaltrials |
| NCT00429403 | Goserelin Acetate Study for Ovarian Function in Patients With Primary Breast Cancer | terminated | Phase 3 | 1 | M.D. Anderson Cancer CenterOTHER | 2 | May 9, 2016 | clinicaltrials |
| NCT00248170 | Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer(FACE) | completed | Phase 3 | 4,172 | Novartis PharmaceuticalsINDUSTRY | 20 | Apr 19, 2016 | clinicaltrials |
| NCT02620371 | Efficacy of Ketamine Added to Local Anesthetic in Modified Pectoral Block for Management of Postoperative Pain | completed | Phase 3 | 60 | Assiut UniversityOTHER | 1 | Apr 19, 2016 | clinicaltrials |
| NCT01530607 | Administration During Chemotherapy to Reduce Ovarian Failure Following Chemotherapy in Early Stage, Hormone-Receptor Negative Breast Cancer | completed | Phase 3 | 416 | King Faisal Specialist Hospital & Research CenterOTHER | 0 | Feb 25, 2016 | clinicaltrials |
| NCT00544232 | Preoperative Epirubicin Paclitaxel Aranesp Study (PREPARE) | completed | Phase 3 | 720 | GBG Forschungs GmbHOTHER | 0 | Feb 15, 2016 | clinicaltrials |
| NCT01426880 | Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer(GeparSixto) | completed | Phase 2 / Phase 3 | 595 | GBG Forschungs GmbHOTHER | 1 | Feb 15, 2016 | clinicaltrials |
| NCT01250379 | A Study of Avastin (Bevacizumab) in Combination With Chemotherapy in Patients With Breast Cancer Progressing After First-Line Therapy With Avastin and Chemotherapy (TANIA) | completed | Phase 3 | 494 | Hoffmann-La RocheINDUSTRY | 13 | Feb 11, 2016 | clinicaltrials |
| NCT00567554 | Bevacizumab, Everolimus (RAD001), and Lapatinib as Neoadjuvant Chemotherapy Regimes for Primary Breast Cancer(GeparQuinto) | completed | Phase 3 | 2,600 | GBG Forschungs GmbHOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT01204437 | Adjuvant Chemotherapy for Elderly Non Frail Patients With an Increased Risk for Relapse of a Primary Carcinoma of the Breast(ICE-II) | completed | Phase 2 / Phase 3 | 400 | GBG Forschungs GmbHOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT01773460 | Everolimus Beyond Progress for Patients Who Had Progress Under Everolimus and Exemestane(Evelyn) | terminated | Phase 3 | 3 | GBG Forschungs GmbHOTHER | 1 | Feb 10, 2016 | clinicaltrials |
| NCT00998738 | Calcium and Magnesium in Preventing Peripheral Neuropathy Caused by Ixabepilone in Patients With Breast Cancer | terminated | Phase 3 | 1 | Mayo ClinicOTHER | 1 | Feb 4, 2016 | clinicaltrials |
| NCT00333775 | A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer | completed | Phase 3 | 736 | Hoffmann-La RocheINDUSTRY | 24 | Jan 27, 2016 | clinicaltrials |
| NCT01112254 | Evaluation of the Diagnostic Performance of MRI±Biopsy to Optimize Resection of Ductal Carcinoma In Situ (DCIS) Breast Cancer(IRCIS) | completed | Phase 3 | 360 | Gustave Roussy, Cancer Campus, Grand ParisOTHER | 1 | Jan 26, 2016 | clinicaltrials |
| NCT02539615 | A Trial of the ForeCYTE Breast Aspirator for Cytological Testing of Nipple Aspirate Fluid in Women 30-55 Years Old | withdrawn | Phase 3 | 0 | Atossa Therapeutics, Inc.INDUSTRY | 1 | Jan 25, 2016 | clinicaltrials |
| NCT00540800 | BREAST-10: Three-weekly Versus Weekly First-line Chemotherapy for Metastatic or Locally Advanced Breast Cancer(BREAST-10) | completed | Phase 3 | 139 | National Cancer Institute, NaplesOTHER | 1 | Jan 14, 2016 | clinicaltrials |
| NCT00305643 | Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer | terminated | Phase 3 | 11 | M.D. Anderson Cancer CenterOTHER | 2 | Dec 24, 2015 | clinicaltrials |
| NCT02058615 | Feasibility Testing and Evaluation of an Online Toolkit for Male Spouses of Women With Breast Cancer | completed | Phase 3 | 57 | University of AlbertaOTHER | 1 | Dec 24, 2015 | clinicaltrials |
| NCT02207335 | Trial of Gemcitabine_Capecitabine Versus Gemcitabine_Carboplatin in Breast Cancer | unknown | Phase 3 | 120 | Tianjin Medical University Cancer Institute and HospitalOTHER | 1 | Dec 22, 2015 | clinicaltrials |
| NCT00202059 | Effects of Zometa and Physical Activity on Bone Density in Women Receiving Chemotherapy for Breast Cancer | completed | Phase 3 | 72 | HealthPartners InstituteOTHER | 1 | Dec 16, 2015 | clinicaltrials |
| NCT00902330 | Cranial Stimulation for Chemotherapy Symptoms in Breast Cancer | completed | Phase 3 | 161 | Virginia Commonwealth UniversityOTHER | 0 | Nov 23, 2015 | clinicaltrials |
| NCT00005975 | S9626: Megestrol in Treating Hot Flashes Following Treatment for Breast Cancer | completed | Phase 3 | 288 | SWOG Cancer Research NetworkNETWORK | 0 | Nov 18, 2015 | clinicaltrials |
| NCT00003162 | Radiation Therapy in Treating Patients With Bone Metastases From Breast or Prostate Cancer | completed | Phase 3 | 949 | Radiation Therapy Oncology GroupNETWORK | 2 | Nov 17, 2015 | clinicaltrials |
| NCT02595138 | Zoledronic Acid as Adjuvant Treatment of Triple-negative Breast Cancer | unknown | Phase 3 | 430 | Chinese Academy of Medical SciencesOTHER | 0 | Nov 3, 2015 | clinicaltrials |
| NCT02336529 | Nerveblocks for Persistent Pain After Breast Cancer Surgery | unknown | Phase 3 | 48 | Kenneth Geving AndersenOTHER | 0 | Oct 27, 2015 | clinicaltrials |
| NCT01809171 | Placebo-controlled Trial With Vitamin D to Prevent Worsening/Relieve Aromatase Inhibitor-induced Musculoskeletal Symptoms in Breast Cancer Patients | terminated | Phase 2 / Phase 3 | 15 | Universitaire Ziekenhuizen KU LeuvenOTHER | 1 | Oct 21, 2015 | clinicaltrials |
| NCT00003906 | Study of Tamoxifen and Raloxifene (STAR) for the Prevention of Breast Cancer in Postmenopausal Women | completed | Phase 3 | 19,747 | NSABP Foundation IncNETWORK | 3 | Oct 6, 2015 | clinicaltrials |
| NCT01509781 | Suction Drain Versus the Use of Adaptive Skin Sutures After Mastectomy ± Axillary Lymphadenectomy; a Prospective Randomised Study | unknown | Phase 3 | 400 | National Institute of Oncology, HungaryOTHER | 1 | Oct 6, 2015 | clinicaltrials |
| NCT01204801 | Randomized Study of Combination Chemotherapy With or Without Focused Microwave Thermotherapy Before Surgery in Treating Women With Large Breast Cancer Tumors(Medifocus301) | unknown | Phase 3 | 238 | Medifocus, Inc.INDUSTRY | 2 | Sep 24, 2015 | clinicaltrials |
| NCT01433614 | Epirubicin and Paclitaxel, Alone or Together With Capecitabine as First Line Treatment in Metastatic Breast Cancer(TEX) | completed | Phase 3 | 304 | Thomas HatschekOTHER | 1 | Sep 17, 2015 | clinicaltrials |
| NCT00375505 | The Safety and Efficacy of Zoledronic Acid in the Prevention of Cancer Therapy Induced Bone Loss | completed | Phase 3 | 70 | Novartis PharmaceuticalsINDUSTRY | 1 | Sep 7, 2015 | clinicaltrials |
| NCT00528567 | BEATRICE Study: A Study of Bevacizumab (Avastin) Adjuvant Therapy in Triple Negative Breast Cancer | completed | Phase 3 | 2,591 | Hoffmann-La RocheINDUSTRY | 40 | Sep 4, 2015 | clinicaltrials |
| NCT00391092 | A Study of Avastin (Bevacizumab) in Combination With Herceptin (Trastuzumab)/Docetaxel in Patients With HER2 Positive Metastatic Breast Cancer. | completed | Phase 3 | 424 | Hoffmann-La RocheINDUSTRY | 16 | Aug 28, 2015 | clinicaltrials |
| NCT02525159 | Effectiveness of DIM Supplements to Increase 2-OHE1/16 Ratio(EDIMI216OHE1) | completed | Phase 3 | 60 | Instituto Nacional de Perinatologia Isidro Espinosa de los ReyesOTHER_GOV | 0 | Aug 17, 2015 | clinicaltrials |
| NCT01281904 | Acupressure for Persistent Cancer Related Fatigue(AcuCrft) | completed | Phase 2 / Phase 3 | 288 | University of MichiganOTHER | 1 | Aug 6, 2015 | clinicaltrials |
Data updated 24 days agoSource updated Jul 13, 2016source: clinicaltrials